A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Clinical trial NCT06413680 · RECRUITING

Trial details

NCT number: NCT06413680
Sponsor: Regeneron Pharmaceuticals
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma Clear-Cell Renal-Cell Carcinoma (ccRCC)Advanced Solid Tumors

Start date: 2024-09-23
Primary completion: 2030-02-03
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.